Obalon Therapeutics, Inc. logo
Obalon Therapeutics, Inc. OBLN

Obalon Therapeutics, Inc. Revenue | OBLN

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Obalon Therapeutics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.59 M 3.28 M 9.1 M 9.91 M 3.39 M 4.04 M 3.54 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
9.91 M 1.59 M 4.98 M

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical devices industry

Issuer Revenue Price % 24h Market Cap Country
Avanos Medical Avanos Medical
AVNS
701 M $ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
12.3 M - 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
40 K - 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
6.02 M $ 1.62 -0.92 % $ 35.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
27.4 M - 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
1 K - -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
104 M - - $ 140 M usaUSA
GBS GBS
GBS
4.22 M - -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
2.55 M - - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
819 K - 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
22 M - 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
30.7 M - - $ 6.6 M usaUSA
Avinger Avinger
AVGR
7.65 M - -20.74 % $ 369 K usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
64.1 M - - $ 162 M franceFrance
Neovasc Neovasc
NVCN
2.55 M - - $ 111 M canadaCanada
ShockWave Medical ShockWave Medical
SWAV
730 M - - $ 12.3 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
409 M - - $ 217 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
6.02 M - 3.58 % $ 2.21 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
366 M - - $ 3.31 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
6.07 B $ 105.14 -0.28 % $ 61.5 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
236 M - 0.15 % $ 844 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
9.44 M - -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
2.13 M - 3.55 % $ 7.96 M usaUSA
Abiomed Abiomed
ABMD
1.03 B - - $ 17.2 B usaUSA
Titan Medical Titan Medical
TMDI
20.1 M - -26.32 % $ 19.6 M canadaCanada
SmileDirectClub SmileDirectClub
SDC
471 M - -53.45 % $ 9.71 M usaUSA
Cutera Cutera
CUTR
49.5 M - -10.19 % $ 1.99 M usaUSA
Sientra Sientra
SIEN
25.1 M - -16.59 % $ 10.3 M usaUSA
Acutus Medical Acutus Medical
AFIB
20.2 M - -26.83 % $ 2.62 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
4.56 B $ 30.34 -0.57 % $ 26.3 B britainBritain
Viveve Medical Viveve Medical
VIVE
6.43 M - -15.35 % $ 1.71 M usaUSA
Penumbra Penumbra
PEN
1.4 B $ 320.36 0.39 % $ 12.5 B usaUSA
Venus Concept Venus Concept
VERO
64.8 M - - $ 726 K usaUSA
Eargo Eargo
EAR
37.2 M - - $ 10.2 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
82 M - -32.98 % $ 1.68 M usaUSA
BIOLASE BIOLASE
BIOL
49.2 M - -13.19 % $ 166 K usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
191 M - 0.28 % $ 270 M usaUSA
Inari Medical Inari Medical
NARI
494 M - - $ 4.23 B usaUSA
Viemed Healthcare Viemed Healthcare
VMD
270 M $ 8.81 -2.87 % $ 343 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
76.9 M - - $ 475 M usaUSA
NuVasive NuVasive
NUVA
1.2 B - - $ 2.07 B usaUSA
Conformis Conformis
CFMS
62 M - - $ 16.4 M usaUSA
Insulet Corporation Insulet Corporation
PODD
2.71 B $ 139.95 -3.71 % $ 9.85 B usaUSA
ViewRay ViewRay
VRAY
102 M - 1.54 % $ 468 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
29.9 M - 10.28 % $ 55.5 M israelIsrael
Vapotherm Vapotherm
VAPO
68.7 M - 6.72 % $ 34 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
177 M - - $ 1.07 B usaUSA
TELA Bio TELA Bio
TELA
80.3 M $ 0.78 2.43 % $ 36.6 M usaUSA
Zynex Zynex
ZYXI
192 M - - $ 21.1 M usaUSA
TransMedics Group TransMedics Group
TMDX
605 M $ 96.58 2.84 % $ 3.28 B usaUSA